Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Baxter
Dow
Cipla
Accenture
Medtronic
Express Scripts
Farmers Insurance
Fish and Richardson

Generated: August 22, 2017

DrugPatentWatch Database Preview

Meclofenamate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for meclofenamate sodium and what is the scope of meclofenamate sodium patent protection?

Meclofenamate sodium
is the generic ingredient in three branded drugs marketed by Watson Labs, Parke Davis, Usl Pharma, Barr, Vitarine, Am Therap, Sandoz, Watson Labs Teva, Par Pharm, Quantum Pharmics, and Mylan, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for meclofenamate sodium. One supplier is listed for this compound.

Summary for Generic Name: meclofenamate sodium

Tradenames:3
Patents:0
Applicants:11
NDAs:22
Drug Master File Entries: see list8
Suppliers / Packagers: see list1
Bulk Api Vendors: see list60
Clinical Trials: see list2,374
Patent Applications: see list5,618
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:meclofenamate sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL070401-001Nov 25, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL072263-001Nov 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL071640-001Aug 11, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL071641-001Aug 11, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
MECLOMEN
meclofenamate sodium
CAPSULE;ORAL018006-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Argus Health
Moodys
Queensland Health
Boehringer Ingelheim
Fish and Richardson
McKesson
Teva
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot